Cabio Biotech (Wuhan) Co., Ltd. - PE Ratio

The PE Ratio as of July 2026 (TTM) for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is 29.27

According to Cabio Biotech (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 29.27. This represents a change of 40.97% compared to the average of 20.76 of the last 4 quarters.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Historical PE Ratio (quarterly & annually)

How has 688089.SS PE Ratio performed in the past?

The mean historical PE Ratio of Cabio Biotech (Wuhan) Co., Ltd. over the last ten years is 48.88. The current 29.27 PE Ratio has changed 5.89% with respect to the historical average. Over the past ten years (40 quarters), 688089.SS's PE Ratio was at its highest in in the March 2023 quarter at 77.61. The PE Ratio was at its lowest in in the December 2022 quarter at -104.69.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cabio Biotech (Wuhan) Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Average PE Ratio

How has 688089.SS PE Ratio performed in the past?

The current PE Ratio of Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) PE Ratio vs. Peers

How is 688089.SS’s PE Ratio compared to its peers?

Cabio Biotech (Wuhan) Co., Ltd.’s PE Ratio is greater than Baolingbao Biology Co.,Ltd. (20.19), greater than Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (-334.76), less than Qingdao Vland Biotech Inc. (42.71), greater than Hvsen Biotechnology Co., Ltd. (16.30), greater than Shanghai ZJ Bio-Tech Co., Ltd. (-62.27), greater than Shanghai Hile Bio-Technology Co., Ltd. (-5.99), greater than Zhejiang Wecome Pharmaceutical Company Limited (-24.02), greater than Hainan Huluwa Pharmaceutical Group Co., Ltd. (-7.37), less than Guanhao Biotech Co.,Ltd. (165.04), less than Yantai Zhenghai Biotechnology Co., Ltd. (39.87),

Build a custom stock screener for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabio Biotech (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabio Biotech (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.